<DOC>
	<DOCNO>NCT00758420</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness polidocanol injectable foam relief symptom , improvement appearance , overall effectiveness safety treatment varicose vein compare placebo .</brief_summary>
	<brief_title>Randomized , Single Blind , Placebo Controlled , Evaluate Efficacy Safety Polidocanol Injectable Foam Treatment Symptomatic , Visible Varicose Veins With SFJ Incompetence</brief_title>
	<detailed_description>The purpose study evaluate efficacy polidocanol injectable foam v placebo treatment relief symptom use two disease specific questionnaire , establishment minimally important difference ( MID ) questionnaires , improvement appearance visible varicosity patient medical assessment aid pre post treatment photograph , central independent assessor evaluate pre post treatment photograph . In addition , study evaluate efficacy polidocanol injectable foam v placebo treatment elimination SFJ reflux occlusion treat vein , determine whether placebo procedure blind patient treatment assignment .</detailed_description>
	<mesh_term>Varicose Veins</mesh_term>
	<mesh_term>Polidocanol</mesh_term>
	<criteria>Males Females 1865 year old VEINES Sym Score less 75 point Varicose Vein clinical classification CEAP 2 , 3 , 4 , 5 Incompetence SFJ associate incompetence GSV major accessory vein Superficial venous disease manifest symptom visible varicosity Ability comprehend sign inform consent document complete study questionnaire English Incompetence SSV substantially contribute fill visible varicose vein Current previous Deep Vein Thrombosis Leg obesity Peripheral arterial disease leg treat Reduced mobility Planned prolong travel limited mobility 4 week treatment History pulmonary embolism stroke Major surgery , prolong hospitalization pregnancy within 3 month Current anticoagulation therapy ( within 7 day enrollment ) Participation clinical study involve investigational product within 3 month Major coexist disease clinically significant laboratory abnormality Known allergic response polidocanol heparin severe and/or multiple allergic reaction Women childbearing potential use effective contraception one month prior enrollment and/or unwilling continue study Pregnant lactate woman Current alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Varicose Veins</keyword>
</DOC>